SI-BONE Financial Ratios
NASDAQ: SIBNHealthcareMedical DevicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SI-BONE ratio analysis
SI-BONE earned a net margin of -9.4% in FY 2025, up from -18.5% a year earlier. Gross margin was 79.6% compared with a median of 88.2% over the prior 8 years. Return on equity reached -10.6%, meaning SI-BONE generated -0.11 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.20 versus 0.21 the year before, and the current ratio was 8.55. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
SI-BONE financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 4.23 | 3.54 | 5.81 | 4.37 | 8.17 | 11.84 | 7.78 | 2.86 | — |
| Price / book | 4.79 | 3.54 | 4.76 | 4.73 | 5.48 | 5.13 | 8.31 | 1.76 | — |
| Gross margin | 79.6% | 79.0% | 78.8% | 85.2% | 88.4% | 87.9% | 89.9% | 91.3% | 89.3% |
| Operating margin | -11.1% | -21.1% | -33.8% | -56.0% | -57.3% | -52.6% | -53.5% | -21.6% | -36.2% |
| Net margin | -9.4% | -18.5% | -31.2% | -57.6% | -62.8% | -59.5% | -57.1% | -31.5% | -48.0% |
| Free cash flow margin | -4.5% | -13.7% | -19.1% | -48.1% | -50.9% | -45.3% | -50.6% | -27.9% | -37.5% |
| Return on equity (ROE) | -10.6% | -18.5% | -25.6% | -62.3% | -42.1% | -25.8% | -60.9% | -19.4% | — |
| Return on assets (ROA) | -7.9% | -13.4% | -18.8% | -38.9% | -29.7% | -19.6% | -32.8% | -12.6% | -64.3% |
| Debt / equity | 0.20 | 0.21 | 0.21 | 0.36 | 0.26 | 0.23 | 0.62 | 0.43 | — |
| Current ratio | 8.55 | 7.66 | 9.01 | 6.50 | 10.41 | 16.20 | 5.94 | 15.11 | 4.46 |
| Revenue growth | 20.2% | 20.4% | 30.5% | 18.0% | 22.8% | 9.0% | 21.5% | 15.4% | — |